The 6 Best Solar Generators Provide Reliable Backup Power in a Pinch

The Solix F2000 has 12 ports, including two car ports, an RV-specific outlet, four AC ports, three USB-C charging ports, and ...
Polygon

Pragmata interactive maps

Pragmata's map is bigger and more full of secrets than you might expect from what initially seems like a series of hallways. Nooks filled with danger and crannies hiding treasure abound, but it's easy ...
Forbes

Generate Biomedicines IPO Turns Heads

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
MedCity News

Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
FierceBiotech

Behind Generate's 'feverish' race to raise $400M IPO while window remains open

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Bloomberg L.P.

Flagship-Backed Generate Biomedicines Raises $400 Million in IPO

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
The Boston Globe

Flagship-backed Generate Biomedicines seeks $425 million in IPO

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Seeking Alpha

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
FierceBiotech

Flagship-founded antibody biotech Generate is latest to mull IPO

Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
The Business Journals

Generate:Biomedicines eyes public markets as AI drug advances to late-stage trials

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...
Local 12 WKRC Cincinnati

Cincinnati to convert old landfill into solar array that could power 1,200 homes

A man faces a felonious assault charge for allegedly stabbing another person in the arm. One of Greater Cincinnati's largest school district names new superintendent One of Greater Cincinnati's ...
Phys.org

Neutral-atom arrays, a rapidly emerging quantum computing platform, get a boost from researchers

Neutral-atom arrays are a rapidly emerging platform to create quantum computers. In a foundational study led by graduate students Aaron Holman and Yuan Xu from the Will and Yu labs, respectively, the ...